You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

From Medscape Education

High Risk Dyslipidemia Management in Asia Pacific

About This Series

This curriculum will address patients with high-risk dyslipidemia and their management from identification, to referral to specialists, all the way though to treatment.

This Educational Series was developed in partnership with the Asian Pacific Society of Cardiology

Studies conducted in Asia demonstrated that only about 30% to 40% of patients with acute coronary syndrome (ACS) or stable coronary heart disease (CHD) achieve their low-density lipoprotein cholesterol (LDL-C) target. Upon completion of these activities, participants will:

  • Have increased knowledge regarding the ability to identify and assess patients with high-risk dyslipidemia to evaluate patient need for treatment beyond statins
  • Have greater competence related to the treatment of patients with high-risk dyslipidemia, particularly regarding initiation and management of treatment with PCSK9 inhibitors

These educational activities are intended for an international audience of Asia-Pacific healthcare professionals, specifically cardiologists, diabetologists & endocrinologists, and primary-care physicians involved in the management of patients with high-risk dyslipidemia    


The following educational programs were developed through a collaboration between

Asian Pacific Society of Cardiology

APSC 2018 for more information visit:

APSC 2018